Rigel Pharmaceuticals (RIGL) Capital Expenditures (2010 - 2023)
Rigel Pharmaceuticals (RIGL) posted quarterly Capital Expenditures of $29000.0 for Q4 2023, down 96.91% year-over-year from $940000.0 in Q4 2022, and up 107.14% quarter-over-quarter from $14000.0 in Q3 2023.
Rigel Pharmaceuticals (RIGL) Capital Expenditures (2010 - 2023) Analysis & Trends
Rigel Pharmaceuticals' Capital Expenditures history runs 14 years deep, the most recent figure standing at $29000.0 for Q4 2023.
- In Q4 2023, Capital Expenditures fell 96.91% year-over-year to $29000.0; the TTM figure through Dec 2023 stood at -$56000.0 (down 112.44% YoY), while the FY2023 annual figure was -$56000.0, down 112.44% from the prior year.
- Capital Expenditures for Q4 2023 stood at $29000.0, up from $14000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.5 million in Q4 2019, with the low at -$678000.0 in Q3 2022.
- The 5-year median for Capital Expenditures is $6500.0 (2023), against an average of $163050.0.
- Peak annual rise in Capital Expenditures reached 10216.67% in 2020, while the deepest fall reached 3962.5% in 2020.
- Rigel Pharmaceuticals' Capital Expenditures stood at $1.5 million in 2019, then fell by 23.88% to $1.1 million in 2020, then sank by 143.76% to -$498000.0 in 2021, then jumped by 288.76% to $940000.0 in 2022, then sank by 96.91% to $29000.0 in 2023.
- Business Quant data shows RIGL's Capital Expenditures at $29000.0 in Q4 2023, $14000.0 in Q3 2023, and -$1000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Dec 31, 2022 | 940,000.00 |
| Dec 31, 2022 | 940,000.00 |
| Sep 30, 2022 | -678,000.00 |
| Sep 30, 2022 | -678,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Dec 31, 2021 | -498,000.00 |
| Dec 31, 2021 | -498,000.00 |
| Sep 30, 2021 | 170,000.00 |
| Sep 30, 2021 | 170,000.00 |